These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5426805)

  • 1. [Experience in active immunization of leprosy in the USSR through BCG vaccination].
    Torsuev NA; Pogorelov V; Davlekamova IF; Kharabadzhakhov K
    Vestn Dermatol Venerol; 1970 Jan; 44(1):76-8. PubMed ID: 5426805
    [No Abstract]   [Full Text] [Related]  

  • 2. BCG vaccination protects against leprosy in Venezuela: a case-control study.
    Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of leprosy. (1) Results of BCG vaccination of family members exposed to leprosy patients in Okinawa].
    Saikawa K
    Nihon Rai Gakkai Zasshi; 1982; 51(2):75-80. PubMed ID: 7169394
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contribution to the study of leprosy and BCG vaccination among the children of lepers and non-family contacts in Iran].
    Assefi V; Gaulier M; Gaulier A
    Acta Leprol; 1984; 2(1):39-45. PubMed ID: 6385599
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Raipur, India.
    Rahete NP; Zodpey SP; Kamble KM
    Indian J Public Health; 2007; 51(2):86-90. PubMed ID: 18240467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG vaccination of children against leprosy. Preliminary findings of the WHO-controlled trial in Burma up to January 1970.
    Bechelli LM; Garbajosa PG; Gyi MM; Uemura K; Engler V; Dominguez VM; Sundaresan T; Quagliato R; Matejka M
    Int J Lepr Other Mycobact Dis; 1971; 39(2):609. PubMed ID: 4260184
    [No Abstract]   [Full Text] [Related]  

  • 7. Long lasting BCG protection against leprosy.
    Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
    Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam.
    Thuc NV; Abel L; Lap VD; Oberti J; Lagrange PH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):532-8. PubMed ID: 7868950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine trials in leprosy--Venezuela, Malawi and India.
    Gupte MD
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S32-7. PubMed ID: 10700935
    [No Abstract]   [Full Text] [Related]  

  • 10. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya.
    Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of BCG in prevention of leprosy: a meta-analysis.
    Setia MS; Steinmaus C; Ho CS; Rutherford GW
    Lancet Infect Dis; 2006 Mar; 6(3):162-70. PubMed ID: 16500597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccine trials against leprosy].
    Gupta MD
    Acta Leprol; 1999; 11(2):45-7. PubMed ID: 19785197
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.
    Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM
    Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative leprosy vaccine trial in south India.
    Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J
    Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG vaccination in leprosy.
    Price JE
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):205-12. PubMed ID: 6749707
    [No Abstract]   [Full Text] [Related]  

  • 16. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculin sensitivity and skin lesions in children after vaccination with two batches of BCG vaccine.
    Vallishayee RS; Anantharaman DS; Gupte MD
    Indian J Lepr; 1998; 70(3):277-86. PubMed ID: 9801900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG vaccination.
    Ironside AG
    Practitioner; 1971 Apr; 206(234):488-93. PubMed ID: 5576887
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effect of BCG against leprosy in South Sulawesi, Indonesia.
    Boelens JJ; Kroes R; van Beers S; Lever P
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):456-7. PubMed ID: 7594932
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
    Zodpey SP; Ambadekar NN; Thakur A
    Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.